Identification of hPIF1 helicase inhibitors by virtual screening of a Fsp3-enriched library

IF 2.5 4区 医学 Q3 CHEMISTRY, MEDICINAL
Mark J.A. Wever , Francesca R. Scommegna , Jean-François Poisson , Vincent Rodeschini , Didier Roche , Cyril M. Sanders
{"title":"Identification of hPIF1 helicase inhibitors by virtual screening of a Fsp3-enriched library","authors":"Mark J.A. Wever ,&nbsp;Francesca R. Scommegna ,&nbsp;Jean-François Poisson ,&nbsp;Vincent Rodeschini ,&nbsp;Didier Roche ,&nbsp;Cyril M. Sanders","doi":"10.1016/j.bmcl.2025.130314","DOIUrl":null,"url":null,"abstract":"<div><div>The PIF1 DNA helicase has functions in genome stability and there is strong evidence for a relation between elevated human PIF1 expression and poor outcomes in cancer patients. Here, we report the discovery, <em>via</em> sequential structure-based virtual screening, of a novel series of compounds that inhibit human PIF1 helicase activity. One active scaffold was identified and confirmed <em>in vitro</em>. Molecular modelling-based design and chemical synthesis ultimately led to the 2,6-diaminopyridine derivative <strong>48</strong> inhibiting hPIF1 with an IC<sub>50</sub> of 320 μM. Our results indicate that the new scaffold of <strong>48</strong> selected from virtual screening exhibits potential as a starting point for novel hPIF1 inhibitors.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"128 ","pages":"Article 130314"},"PeriodicalIF":2.5000,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960894X25002239","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

The PIF1 DNA helicase has functions in genome stability and there is strong evidence for a relation between elevated human PIF1 expression and poor outcomes in cancer patients. Here, we report the discovery, via sequential structure-based virtual screening, of a novel series of compounds that inhibit human PIF1 helicase activity. One active scaffold was identified and confirmed in vitro. Molecular modelling-based design and chemical synthesis ultimately led to the 2,6-diaminopyridine derivative 48 inhibiting hPIF1 with an IC50 of 320 μM. Our results indicate that the new scaffold of 48 selected from virtual screening exhibits potential as a starting point for novel hPIF1 inhibitors.

Abstract Image

通过虚拟筛选fsp3富集文库鉴定hif1解旋酶抑制剂。
PIF1 DNA解旋酶在基因组稳定性中具有功能,并且有强有力的证据表明人类PIF1表达升高与癌症患者预后不良之间存在关联。在这里,我们报告了通过基于序列结构的虚拟筛选发现的一系列抑制人类PIF1解旋酶活性的新化合物。在体外鉴定并确认了一个活性支架。基于分子模型的设计和化学合成最终得到抑制hPIF1的2,6-二氨基吡啶衍生物48,IC50为320 μM。我们的研究结果表明,从虚拟筛选中选择的48个新支架具有作为新型hPIF1抑制剂的起点的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.70
自引率
3.70%
发文量
463
审稿时长
27 days
期刊介绍: Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信